E-viri
Recenzirano
Odprti dostop
-
Dewaeles, Edmone; Carvalho, Kévin; Fellah, Sandy; Sim, Jaewon; Boukrout, Nihad; Caillierez, Raphaelle; Ramakrishnan, Hariharan; Van der Hauwaert, Cynthia; Vijaya Shankara, Jhenkruthi; Martin, Nathalie; Massri, Noura; Launay, Agathe; Folger, Joseph K; de Schutter, Clémentine; Larrue, Romain; Loison, Ingrid; Goujon, Marine; Jung, Matthieu; Le Gras, Stéphanie; Gomez-Murcia, Victoria; Faivre, Emilie; Lemaire, Julie; Garat, Anne; Beauval, Nicolas; Maboudou, Patrice; Gnemmi, Viviane; Gibier, Jean-Baptiste; Buée, Luc; Abbadie, Corinne; Glowacki, Francois; Pottier, Nicolas; Perrais, Michael; Cunha, Rodrigo A; Annicotte, Jean-Sébastien; Laumet, Geoffroy; Blum, David; Cauffiez, Christelle
The Journal of clinical investigation, 11/2022, Letnik: 132, Številka: 22Journal Article
Cisplatin is a potent chemotherapeutic drug that is widely used in the treatment of various solid cancers. However, its clinical effectiveness is strongly limited by frequent severe adverse effects, in particular nephrotoxicity and chemotherapy-induced peripheral neuropathy. Thus, there is an urgent medical need to identify novel strategies that limit cisplatin-induced toxicity. In the present study, we show that the FDA-approved adenosine A2A receptor antagonist istradefylline (KW6002) protected from cisplatin-induced nephrotoxicity and neuropathic pain in mice with or without tumors. Moreover, we also demonstrate that the antitumoral properties of cisplatin were not altered by istradefylline in tumor-bearing mice and could even be potentiated. Altogether, our results support the use of istradefylline as a valuable preventive approach for the clinical management of patients undergoing cisplatin treatment.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.